WO2000002999A3 - Medium and matrix for long-term proliferation of cells - Google Patents
Medium and matrix for long-term proliferation of cells Download PDFInfo
- Publication number
- WO2000002999A3 WO2000002999A3 PCT/US1999/015464 US9915464W WO0002999A3 WO 2000002999 A3 WO2000002999 A3 WO 2000002999A3 US 9915464 W US9915464 W US 9915464W WO 0002999 A3 WO0002999 A3 WO 0002999A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- hydrogel matrix
- amino acids
- matrix
- culture medium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/114—Nitric oxide, i.e. NO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU49772/99A AU758833B2 (en) | 1998-07-10 | 1999-07-09 | Medium and matrix for long-term proliferation of cells |
CA2332701A CA2332701C (en) | 1998-07-10 | 1999-07-09 | Medium and matrix for long-term proliferation of cells |
JP2000559221A JP2002520013A (en) | 1998-07-10 | 1999-07-09 | Medium and substrate for long-term cell growth |
EP99933791A EP1098959A2 (en) | 1998-07-10 | 1999-07-09 | Medium and matrix for long-term proliferation of cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/113,437 | 1998-07-10 | ||
US09/113,437 US6231881B1 (en) | 1992-02-24 | 1998-07-10 | Medium and matrix for long-term proliferation of cells |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000002999A2 WO2000002999A2 (en) | 2000-01-20 |
WO2000002999A3 true WO2000002999A3 (en) | 2000-04-20 |
Family
ID=22349408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/015464 WO2000002999A2 (en) | 1998-07-10 | 1999-07-09 | Medium and matrix for long-term proliferation of cells |
Country Status (9)
Country | Link |
---|---|
US (5) | US6231881B1 (en) |
EP (1) | EP1098959A2 (en) |
JP (1) | JP2002520013A (en) |
AT (2) | ATE449619T1 (en) |
AU (1) | AU758833B2 (en) |
CA (1) | CA2332701C (en) |
DE (1) | DE69941707D1 (en) |
ES (1) | ES2337320T3 (en) |
WO (1) | WO2000002999A2 (en) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6703017B1 (en) | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US6905707B2 (en) * | 1998-05-28 | 2005-06-14 | Medical Research Institute | Controlled release arginine alpha ketoglutarate |
EP1025861A1 (en) * | 1999-02-04 | 2000-08-09 | Roche Diagnostics GmbH | Pharmaceutical compositions of hydrophobically modified Hedgehog Proteins and their use |
US20090047325A1 (en) * | 1999-04-30 | 2009-02-19 | Neurotrophincell Pty. Limited | Xenotransplant for cns therapy |
US20050265977A1 (en) * | 1999-04-30 | 2005-12-01 | Elliott Robert B | Xenotransplant for CNS therapy |
WO2000066188A2 (en) * | 1999-04-30 | 2000-11-09 | Diatranz Limited | Xenotransplant for cns therapy |
WO2001019962A2 (en) * | 1999-09-15 | 2001-03-22 | Encelle, Inc. | Method of preserving tissue viability during mechanical separation process |
DK1248640T3 (en) * | 2000-01-20 | 2007-02-12 | Diabcell Pty Ltd | Xenotransplantation of pig islets and their production |
WO2001091773A2 (en) * | 2000-05-31 | 2001-12-06 | Encelle, Inc. | Method of stimulating hair growth |
US20040014212A1 (en) * | 2000-10-17 | 2004-01-22 | Elliott Robert Bartlett | Preparation and xenotransplantation or porcine islets |
US20020188170A1 (en) * | 2001-04-27 | 2002-12-12 | Santamore William P. | Prevention of myocardial infarction induced ventricular expansion and remodeling |
WO2002092783A2 (en) * | 2001-05-15 | 2002-11-21 | Children's Medical Center Corporation | Methods and apparatus for application of micro-mechanical forces to tissues |
US20040097401A1 (en) * | 2002-11-14 | 2004-05-20 | Debatosh Datta | Lysine in therapeutic angiogenesis, particularly in treating ischaemic conditions |
US6702744B2 (en) | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
US7156877B2 (en) | 2001-06-29 | 2007-01-02 | The Regents Of The University Of California | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs |
US6790455B2 (en) * | 2001-09-14 | 2004-09-14 | The Research Foundation At State University Of New York | Cell delivery system comprising a fibrous matrix and cells |
US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
AU2003215330B2 (en) | 2002-02-21 | 2008-03-13 | Encelle, Inc. | Immobilized bioactive hydrogel matrices as surface coatings |
US20080086792A1 (en) | 2006-10-13 | 2008-04-17 | Thomas Charles Kuracina | Method and apparatus for diverting sweat, liquid, moisture or the like from an eye |
US20030228287A1 (en) * | 2002-06-07 | 2003-12-11 | Regents Of The University Of California | Maintenance of islet cells |
US7361368B2 (en) | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
JP2005534303A (en) * | 2002-07-30 | 2005-11-17 | マサチューセッツ・インスティテュート・オブ・テクノロジー | Primary hepatocyte perfusion and plating methods and media used therefor |
EP1391284A1 (en) * | 2002-08-23 | 2004-02-25 | Kasai Kogyo Co., Ltd. | Laminated structure and method for manufacturing the same |
US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US7641643B2 (en) | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
EP2514445B1 (en) * | 2003-10-22 | 2018-07-18 | Encelle, Inc. | Bioactive hydrogel compositions for the regeneration of connective tissue |
US20050245905A1 (en) * | 2004-04-30 | 2005-11-03 | Schmidt Steven P | Local drug-delivery system |
JP2008505650A (en) * | 2004-07-12 | 2008-02-28 | ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ | Apparatus and method for growing human cells |
US7784697B2 (en) | 2004-12-23 | 2010-08-31 | University Of Washington | Methods of driving a scanning beam device to achieve high frame rates |
US20060178696A1 (en) * | 2005-02-04 | 2006-08-10 | Porter Stephen C | Macroporous materials for use in aneurysms |
US9427496B2 (en) | 2005-02-18 | 2016-08-30 | Drexel University | Method for creating an internal transport system within tissue scaffolds using computer-aided tissue engineering |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
US8303972B2 (en) | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US9942511B2 (en) | 2005-10-31 | 2018-04-10 | Invention Science Fund I, Llc | Preservation/degradation of video/audio aspects of a data stream |
NZ540597A (en) * | 2005-06-08 | 2007-02-23 | Neurotrophincell Pty Ltd | A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells |
WO2007019461A2 (en) * | 2005-08-08 | 2007-02-15 | Angstrom Medica, Inc. | Cement products and methods of making and using the same |
DE102005054937A1 (en) * | 2005-11-17 | 2007-05-24 | Gelita Ag | Angiogenesis promoting substrate |
AU2006349611A1 (en) | 2005-11-30 | 2008-05-02 | Massachusetts Institute Of Technology | Pathogen-detecting cell preservation systems |
US20070231901A1 (en) * | 2005-12-02 | 2007-10-04 | Shuichi Takayama | Microfluidic cell culture media |
EP1968628A2 (en) * | 2005-12-28 | 2008-09-17 | Essential Skincare, LLC | Transferrin and transferrin-based compositions for diabetes treatment |
US8999933B2 (en) * | 2006-01-18 | 2015-04-07 | Biolitec Pharma Marketing Ltd | Photodynamic cosmetic procedure and healing method |
WO2007087570A2 (en) * | 2006-01-24 | 2007-08-02 | Northfield Laboratories, Inc. | Polymerized hemoglobin media and its use in isolation and transplantation of islet cells |
US20090004159A1 (en) * | 2006-01-24 | 2009-01-01 | The Board Of Trustees Of The University Of Illinoi | Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
US7732190B2 (en) | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US20080069855A1 (en) * | 2006-08-21 | 2008-03-20 | Bonutti Peter M | Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
CN101517067B (en) * | 2006-09-21 | 2014-08-06 | 特苏詹尼斯公司 | Cell delivery matrices |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
EP2117470B1 (en) | 2007-02-06 | 2013-03-06 | Pioneer Surgical Technology, Inc. | Intervertebral implant devices |
DK2155248T3 (en) | 2007-04-12 | 2015-09-14 | Brigham & Womens Hospital | Targeting abcb5 for cancer therapy |
US8057446B2 (en) | 2007-05-01 | 2011-11-15 | The Brigham And Women's Hospital, Inc. | Wound healing device |
DE102007024239A1 (en) * | 2007-05-16 | 2008-11-20 | Gelita Ag | Angiogenesis promoting substrate |
WO2009029734A2 (en) | 2007-08-28 | 2009-03-05 | Pioneer Surgical Technology, Inc. | Cement products and methods of making and using the same |
US20120301444A1 (en) * | 2007-09-27 | 2012-11-29 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
US20090090214A1 (en) * | 2007-10-04 | 2009-04-09 | Chung Yuan Christian University | Method for forming nano-scale metal particles |
EP2222159B1 (en) * | 2007-11-20 | 2018-02-21 | Pioneer Surgical Orthobiologics, Inc. | Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles |
EP2273952B1 (en) | 2008-04-02 | 2018-02-21 | Pioneer Surgical Technology, Inc. | Intervertebral implant devices for supporting vertebrae and devices for insertion thereof |
WO2009137074A1 (en) * | 2008-05-06 | 2009-11-12 | Indigene Pharmaceuticals, Inc. | Compositions and methods for treating diabetic ulcers |
JP5756108B2 (en) | 2009-08-28 | 2015-07-29 | セルノバ コーポレイション | Methods and devices for cell transplantation |
CN106913902A (en) | 2009-11-09 | 2017-07-04 | 聚光灯技术合伙有限责任公司 | Polysaccharide based aquagel |
US8795727B2 (en) | 2009-11-09 | 2014-08-05 | Spotlight Technology Partners Llc | Fragmented hydrogels |
KR102493613B1 (en) * | 2010-05-07 | 2023-01-31 | 유니버시티 오브 노스캐롤라이나 앳 채플 힐 | Method of engrafting cells from solid tissues |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
JP5808631B2 (en) * | 2011-09-29 | 2015-11-10 | 富士フイルム株式会社 | Angiogenic scaffold and method for producing blood vessel for regenerative medicine |
US9132021B2 (en) | 2011-10-07 | 2015-09-15 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
EP2776052B1 (en) | 2011-11-02 | 2017-06-14 | Halscion, Inc. | Methods and compositions for wound treatment |
MX352601B (en) | 2011-12-23 | 2017-11-30 | Pioneer Surgical Tech | Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith. |
EP2820428A1 (en) | 2012-03-01 | 2015-01-07 | 3M Innovative Properties Company | Method of promoting wound healing |
US9101707B2 (en) | 2012-04-27 | 2015-08-11 | Gregory Zeltser | Implantable bioartificial perfusion system |
WO2014089472A1 (en) * | 2012-12-07 | 2014-06-12 | Kansas State University Research Foundation | Peptide-albumin hydrogel properties and its applications |
EP3865573A1 (en) | 2013-02-19 | 2021-08-18 | Children's Medical Center Corporation | Abcb5(+) stem cells for treating ocular disease |
DK2994173T3 (en) | 2013-05-10 | 2021-10-11 | Childrens Medical Center | Wound healing and tissue engineering |
US9616046B2 (en) | 2013-06-28 | 2017-04-11 | Japan Bio Products Co., Ltd. | Hepatocyte-proliferating agent |
CN105992816B (en) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | Cell amplification in bioreactor |
EP3122866B1 (en) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Passive replacement of media |
EP3198006B1 (en) | 2014-09-26 | 2021-03-24 | Terumo BCT, Inc. | Scheduled feed |
SG10201906716QA (en) | 2015-01-20 | 2019-08-27 | Miragen Therapeutics Inc | Mir-92 inhibitors and uses thereof |
US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
TWI664412B (en) | 2016-10-04 | 2019-07-01 | 全崴生技股份有限公司 | Compositions and methods for maintaining cell viability |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
US11702634B2 (en) | 2017-03-31 | 2023-07-18 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
WO2019021143A1 (en) * | 2017-07-22 | 2019-01-31 | Rangasamy Naidu Educational Trust | L- histidine molecule based hydrogel |
WO2019051260A1 (en) | 2017-09-08 | 2019-03-14 | Pioneer Surgical Technology, Inc. | Intervertebral implants, instruments, and methods |
USD907771S1 (en) | 2017-10-09 | 2021-01-12 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0213908A2 (en) * | 1985-08-26 | 1987-03-11 | Hana Biologics, Inc. | Transplantable artificial tissue and process |
US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
EP0481791A2 (en) * | 1990-10-17 | 1992-04-22 | The Wellcome Foundation Limited | Culture medium for CHO-cells and adapted CHO-cells |
WO1994008702A1 (en) * | 1992-10-19 | 1994-04-28 | University Of Utah | Implantable and refillable biohybrid artificial pancreas |
WO1995029231A1 (en) * | 1994-04-21 | 1995-11-02 | Genzyme Corporation | Serum-free medium supplement |
WO1997039107A2 (en) * | 1996-04-12 | 1997-10-23 | The Governors Of The University Of Alberta | Methods for increasing the maturation of cells |
WO1998004681A2 (en) * | 1996-07-25 | 1998-02-05 | Genzyme Corporation | Chondrocyte media formulations and culture procedures |
WO1998016629A1 (en) * | 1996-10-11 | 1998-04-23 | Life Technologies, Inc. | Defined systems for epithelial cell culture and use thereof |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4477567A (en) | 1977-12-01 | 1984-10-16 | Connaught Laboratories Limited | Continuous bovine beta cell line |
US4198479A (en) | 1979-03-30 | 1980-04-15 | Merck & Co., Inc. | Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells |
US4520821A (en) | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
US5132223A (en) | 1983-11-10 | 1992-07-21 | Thomas Jefferson University | Process and medium for cloning and long-term serial cultivation of adult human endothelial cells |
US4868121A (en) | 1985-02-07 | 1989-09-19 | Mcdonnell Douglas Corporation | Islet isolation process |
US4978616A (en) | 1985-02-28 | 1990-12-18 | Verax Corporation | Fluidized cell cultivation process |
NO166836C (en) * | 1985-03-14 | 1991-09-11 | Univ California | PROCEDURE FOR TREATMENT OF AN ORGAN TRANSPLANT. |
US4997753A (en) | 1985-04-04 | 1991-03-05 | Verax Corporation | Weighted collagen microsponge for immobilizing bioactive material |
US4863856A (en) | 1985-04-04 | 1989-09-05 | Verax Corporation | Weighted collagen microsponge for immobilizing bioactive materials |
US5100783A (en) | 1985-05-10 | 1992-03-31 | Verax Corporation | Weighted microsponge for immobilizing bioactive material |
US4902295A (en) | 1985-08-26 | 1990-02-20 | Hana Biologics, Inc. | Transplantable artificial tissue |
GB8604497D0 (en) | 1986-02-24 | 1986-04-03 | Connaught Lab | Separation of islets of langerhans |
FR2600076A1 (en) | 1986-06-12 | 1987-12-18 | Fond Ctre Nal Transfusion | CULTURE MEDIUM COMPRISING HUMAN ALBUMIN, PROCESS FOR PREPARING A PRODUCT INJECTABLE THEREFROM, PRODUCT OBTAINED AND USE THEREOF, COMPOSITION OBTAINED |
US5079160A (en) | 1987-06-08 | 1992-01-07 | Lacy Paul E | Method to isolate clusters of cell subtypes from organs |
US5457093A (en) * | 1987-09-18 | 1995-10-10 | Ethicon, Inc. | Gel formulations containing growth factors |
AU632273B2 (en) * | 1988-03-09 | 1992-12-24 | Terumo Kabushiki Kaisha | Medical material permitting cells to enter thereinto and artificial skin |
US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
EP0363125A3 (en) | 1988-10-03 | 1990-08-16 | Hana Biologics Inc. | Proliferated pancreatic endocrine cell product and process |
US4957902A (en) * | 1988-12-20 | 1990-09-18 | Board Of Regents, The University Of Texas System | Peptide inhibitors of wound contraction |
US5196185A (en) * | 1989-09-11 | 1993-03-23 | Micro-Collagen Pharmaceutics, Ltd. | Collagen-based wound dressing and method for applying same |
WO1991009119A1 (en) | 1989-12-13 | 1991-06-27 | Trancel Corporation | Improved alginate microcapsules, methods of making and using same |
US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US5192312A (en) | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
AU666118B2 (en) | 1991-04-25 | 1996-02-01 | Brown University Research Foundation | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
EP0605428B9 (en) | 1991-06-24 | 2003-01-02 | hCell Technology, Inc. | Hormone-secreting pancreatic cells maintained in long-term culture |
CA2071137A1 (en) | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
US5116753A (en) | 1991-07-30 | 1992-05-26 | The Salk Institute For Biological Studies | Maintenance of pancreatic islets |
US5591709A (en) * | 1991-08-30 | 1997-01-07 | Life Medical Sciences, Inc. | Compositions and methods for treating wounds |
WO1994015589A1 (en) | 1992-12-30 | 1994-07-21 | Clover Consolidated, Limited | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5824331A (en) | 1992-02-24 | 1998-10-20 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
EP0587840B1 (en) | 1992-02-24 | 1999-12-15 | Encelle, Inc. | Bioartificial endocrine device |
US5830492A (en) | 1992-02-24 | 1998-11-03 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
US5834005A (en) | 1992-02-24 | 1998-11-10 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
DE69330640T2 (en) | 1992-05-29 | 2002-07-04 | Vivorx Inc | MICRO-ENCLOSURE OF CELLS |
AU4788993A (en) | 1992-07-29 | 1994-03-03 | Washington University | Use of pouch for implantation of living cells |
DE4431598C2 (en) | 1993-03-03 | 1997-03-20 | Michael Sittinger | Process for producing an implant from cell cultures |
US5405772A (en) | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
JPH09510182A (en) | 1993-11-17 | 1997-10-14 | エルディーエス・テクノロジーズ・インコーポレーテッド | Encapsulated transparent liquid for drug delivery |
DK1418228T3 (en) | 1994-01-13 | 2006-07-17 | Rogosin Inst | Macro-encapsulated secretory cells |
US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
US5840059A (en) | 1995-06-07 | 1998-11-24 | Cardiogenesis Corporation | Therapeutic and diagnostic agent delivery |
WO1997002569A1 (en) | 1995-07-03 | 1997-01-23 | Autronic Plastics, Inc. | Package and storage unit for digital information storage media |
US5681587A (en) | 1995-10-06 | 1997-10-28 | Desmos, Inc. | Growth of adult pancreatic islet cells |
US5672361A (en) | 1996-03-29 | 1997-09-30 | Desmos, Inc. | Laminin 5 for growth of pancreatic islet cells |
-
1998
- 1998-07-10 US US09/113,437 patent/US6231881B1/en not_active Expired - Fee Related
-
1999
- 1999-06-22 US US09/337,959 patent/US6261587B1/en not_active Expired - Fee Related
- 1999-07-09 CA CA2332701A patent/CA2332701C/en not_active Expired - Fee Related
- 1999-07-09 AU AU49772/99A patent/AU758833B2/en not_active Ceased
- 1999-07-09 ES ES99933792T patent/ES2337320T3/en not_active Expired - Lifetime
- 1999-07-09 WO PCT/US1999/015464 patent/WO2000002999A2/en not_active Application Discontinuation
- 1999-07-09 DE DE69941707T patent/DE69941707D1/en not_active Expired - Lifetime
- 1999-07-09 EP EP99933791A patent/EP1098959A2/en not_active Withdrawn
- 1999-07-09 AT AT99933792T patent/ATE449619T1/en not_active IP Right Cessation
- 1999-07-09 AT AT99935483T patent/ATE326243T1/en not_active IP Right Cessation
- 1999-07-09 JP JP2000559221A patent/JP2002520013A/en active Pending
-
2001
- 2001-01-11 US US09/758,793 patent/US6315994B2/en not_active Expired - Fee Related
- 2001-01-11 US US09/758,676 patent/US6730315B2/en not_active Expired - Fee Related
- 2001-01-19 US US09/766,330 patent/US6713079B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
EP0213908A2 (en) * | 1985-08-26 | 1987-03-11 | Hana Biologics, Inc. | Transplantable artificial tissue and process |
EP0481791A2 (en) * | 1990-10-17 | 1992-04-22 | The Wellcome Foundation Limited | Culture medium for CHO-cells and adapted CHO-cells |
WO1994008702A1 (en) * | 1992-10-19 | 1994-04-28 | University Of Utah | Implantable and refillable biohybrid artificial pancreas |
WO1995029231A1 (en) * | 1994-04-21 | 1995-11-02 | Genzyme Corporation | Serum-free medium supplement |
WO1997039107A2 (en) * | 1996-04-12 | 1997-10-23 | The Governors Of The University Of Alberta | Methods for increasing the maturation of cells |
WO1998004681A2 (en) * | 1996-07-25 | 1998-02-05 | Genzyme Corporation | Chondrocyte media formulations and culture procedures |
WO1998016629A1 (en) * | 1996-10-11 | 1998-04-23 | Life Technologies, Inc. | Defined systems for epithelial cell culture and use thereof |
Also Published As
Publication number | Publication date |
---|---|
DE69941707D1 (en) | 2010-01-07 |
ATE449619T1 (en) | 2009-12-15 |
ATE326243T1 (en) | 2006-06-15 |
US6231881B1 (en) | 2001-05-15 |
WO2000002999A2 (en) | 2000-01-20 |
ES2337320T3 (en) | 2010-04-22 |
US6261587B1 (en) | 2001-07-17 |
AU4977299A (en) | 2000-02-01 |
AU758833B2 (en) | 2003-04-03 |
JP2002520013A (en) | 2002-07-09 |
US20010010826A1 (en) | 2001-08-02 |
US20010019841A1 (en) | 2001-09-06 |
US20010007658A1 (en) | 2001-07-12 |
US6315994B2 (en) | 2001-11-13 |
US6713079B2 (en) | 2004-03-30 |
CA2332701A1 (en) | 2000-01-20 |
US6730315B2 (en) | 2004-05-04 |
CA2332701C (en) | 2010-04-20 |
EP1098959A2 (en) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000002999A3 (en) | Medium and matrix for long-term proliferation of cells | |
Hartmeier | Immobilized biocatalysts: an introduction | |
EP1321516B1 (en) | Hydrogel matrix for cellular tissue storage | |
EP1983044A3 (en) | Animal cell culture media comprising plant-derived nutrients | |
GB9314886D0 (en) | Production of a biological control agent | |
WO2000060051A3 (en) | Arpe-19 as a platform cell line for encapsulated cell-based delivery | |
ATE433494T1 (en) | METHOD FOR PRODUCING L-AMINO ACIDS BY FERMENTING A BACTERIUM WITH INCREASED EXPRESSION OF XYLOSE USING GENES | |
ATE275205T1 (en) | AMIDASE | |
WO1999057246A8 (en) | Animal cell culture media comprising non-animal or plant-derived nutrients | |
DE602004014263D1 (en) | RGD-enriched gelatin-like proteins with enhanced cell binding | |
PT936861E (en) | METHOD FOR INCREASING THE EFFICIENCY OF A FERTILIZER | |
ATE282705T1 (en) | IMPROVED BARSTAR GENE | |
NZ504486A (en) | Attaching substances to micro-organisms | |
CA2410968A1 (en) | Method of treating chronic ulcers | |
CA2150526A1 (en) | Biotechnological process for the preparation of cyclic s-.alpha.-amino carboxylic acids and r-.alpha.-amino carboxamides | |
JP2003310297A5 (en) | ||
JP2928727B2 (en) | Method for treating cultured skin for storage and transportation | |
ATE225183T1 (en) | USE OF HEPATOCYTE GROWTH FACTOR TO INDUCE PROLIFERATION AND DIFFERENTIATION OF HEMATOPOIETIC CELLS | |
CA2252616A1 (en) | Biocatalysts with amine acylase activity | |
CA2256369A1 (en) | A process for encapsulating viable animal cells | |
Markvicheva et al. | Gel-immobilized enzymes as promising biocatalysts: Results from Indo-Russian collaborative studies | |
WO1996005286A3 (en) | Cell death accelerator and cell death inhibitor | |
DE68913602T2 (en) | Tissue immobilization and cell culture system and method for attaching biologically active parts to a substrate. | |
CN111019887A (en) | Culture method for preventing dedifferentiation of chondrocytes | |
EA200500905A1 (en) | RECEIVING PSEVUDOMYCINA PSEUDOMONAS SYRINGAE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2332701 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2000 559221 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999933791 Country of ref document: EP Ref document number: 49772/99 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1999933791 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 49772/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999933791 Country of ref document: EP |